MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Momenta Pharmaceuticals Company Profile (NASDAQ:MNTA)

Consensus Ratings for Momenta Pharmaceuticals (NASDAQ:MNTA) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: $24.86 (22.03% upside)

Analysts' Ratings History for Momenta Pharmaceuticals (NASDAQ:MNTA)
Show:
DateFirmActionRatingPrice TargetActions
8/24/2015Sanford C. BernsteinReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2015Sanford C. BernsteinBoost Price TargetOutperform$25.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Goldman SachsDowngradeBuy -> Neutral$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Brean CapitalReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Cowen and CompanyReiterated RatingHold$18.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Leerink SwannBoost Price TargetOutperform$25.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Brean CapitalReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015Brean CapitalReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Stifel NicolausBoost Price TargetBuy$26.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Brean CapitalBoost Price TargetBuy$25.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015Stifel NicolausInitiated CoverageBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Brean CapitalReiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Leerink SwannBoost Price TargetOutperform$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2015Leerink SwannBoost Price TargetOutperform$16.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2015Brean CapitalBoost Price TargetBuy$15.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Brean CapitalReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Maxim GroupSet Price TargetSell$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/23/2015Maxim GroupDowngradeBuy -> Sell$17.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Brean CapitalInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2014Maxim GroupInitiated CoverageBuy$24.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014Goldman SachsInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Maxim GroupInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Bank of AmericaUpgradeUnderperform -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Canaccord GenuityReiterated RatingBuy$22.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2013Sanford C. BernsteinBoost Price TargetOutperform$20.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2013R. F. LaffertyInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/29/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha